Clinical Trial Update: Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing donor IL-15-stimulated NK cell infusion after transplantation for acute leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• donor IL-15-stimulated NK cells

Snippet

Sponsor: Martín, José Luis Díez, M.D. | Conditions: ACUTE LEUKEMIA | Phase 1, Phase 2 | Status: COMPLETED